- Home
- SRTS vs NTIP Comparison
SRTS vs NTIP Comparison
Compare SRTS & NTIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SRTS | NTIP |
|---|---|---|
| Founded | 2010 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Multi-Sector Companies |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.6M | 37.3M |
| IPO Year | 2016 | 2013 |
Fundamental Metrics
Financial Performance| Metric | SRTS | NTIP |
|---|---|---|
| Price | $2.83 | $1.58 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $5.38 | N/A |
| AVG Volume (30 Days) | ★ 15.8K | 7.4K |
| Earning Date | 11-09-2026 | 11-09-2026 |
| Dividend Yield | N/A | ★ 6.33% |
| EPS Growth | N/A | ★ 15.38 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,482,000.00 | $150,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $41.11 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 50.00 |
| 52 Week Low | $2.66 | $1.24 |
| 52 Week High | $5.49 | $1.75 |
Technical Indicators
Market Signals| Indicator | SRTS | NTIP |
|---|---|---|
| Relative Strength Index (RSI) | 40.48 | 48.54 |
| Support Level | $2.75 | $1.42 |
| Resistance Level | $3.17 | $1.57 |
| Average True Range (ATR) | 0.13 | 0.07 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 27.78 | 50.00 |
Price Performance
Historical ComparisonAbout SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
About NTIP Network-1 Technologies Inc.
Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property assets. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.